Program Description:
Chronic spontaneous urticaria (CSU) is an underrecognized condition marked by persistent hives, itch, and angioedema that can disrupt sleep, quality of life, and daily functioning. A deeper understanding of CSU pathophysiology has contributed to the expanding therapeutic landscape, which now includes an oral Bruton tyrosine kinase inhibitor as a noninjectable option for patients who cannot use or prefer not to use injectable biologic therapies. This growing array of distinct treatments adds complexity to managed care decision-making, requiring formulary and utilization management strategies that keep pace with evolving evidence. Diagnostic challenges that delay appropriate CSU identification, evolving clinical guidelines, and unclear treatment sequencing can stall patients on inadequate therapy longer than necessary, driving up health care costs and utilization. Participants will be able to apply practical tools to patient selection and coverage decisions while supporting formulary and access strategies that guide treatment sequencing and improve long-term outcomes for patients with CSU.
Target audience: Managed care pharmacists
Type of activity: Application
Release date: November 11, 2026
Expiration date: November 30, 2026
Time
to complete activity: 1.0 hour
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify the clinical and economic burden, diagnostic challenges, and unmet needs associated with chronic spontaneous urticaria (CSU)
- Determine the comparative value of current and emerging therapies for CSU, including biologics and novel oral targeted agents, based on mechanisms of action, clinical efficacy, safety, durability of response, and patient-reported outcomes
- Explore formulary, coverage, and utilization management strategies to improve access to appropriate CSU therapies while supporting cost-effective, value-based care and optimizing patient adherence and outcomes
Crystal Wright
Accreditation Information
Pharmacy
Times
Continuing Education™ is accredited by the Accreditation Council for Pharmacy
Education (ACPE) as a provider of continuing pharmacy education. This
application-based activity is approved for 1.0 contact hour (0.10 CEU) under
the ACPE universal activity number 0290-9999-26-325-L01-P. The activity is available for CE credit through January 10,
2027.
Obtaining Credit
All participants who attended the live virtual broadcast need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Instructions on receiving credit will be provided the day of the event.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Sarah Viruet; and Brianna Winters have no financial relationships with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
At least 1 anonymous peer reviewer has been used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not
constitute any form of professional advice or referral. Discussions concerning
drugs, dosages, and procedures may reflect the clinical experience of the
author(s) or they may be derived from the professional literature or other
sources and may suggest uses that are investigational in nature and not
approved labeling or indications. Participants are encouraged to refer to primary
references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms